Almakhdob Mohammed, Selim Mohie, Abdalrouf Abuobieda
Preventive Medicine, Family and Community Medicine Administration, Prince Sultan Military Medical City (PSMMC), Riyadh, SAU.
Cureus. 2024 Aug 13;16(8):e66761. doi: 10.7759/cureus.66761. eCollection 2024 Aug.
Herpes zoster, or shingles, is a significant health concern for older adults caused by the varicella-zoster virus (VZV) reactivation. The availability of effective herpes zoster vaccines offers a crucial preventive measure to reduce the incidence and severity of this condition. However, the uptake of the available vaccine remains suboptimal, especially among adults aged 50 and above. Understanding the factors that influence vaccine utilization is not only essential for developing strategies to improve vaccination rates but also has the potential to significantly reduce the disease burden.
This cross-sectional study aimed to identify factors influencing herpes zoster vaccine utilization among adults aged 50 and above attending primary healthcare center in Saudi Arabia. Data were collected using a validated questionnaire administered to visitors attending Al-Wazarat Primary Healthcare Center in Riyadh. Descriptive and inferential statistics were employed to analyze the data.
A total of 403 participants were included in the study, with 73.7% of participants having heard of the disease, yet only 34.2% had received the vaccine. Vaccine uptake was significantly associated with gender, educational level, and healthcare provider recommendations. Common barriers to vaccination included fear of side effects, lack of perceived susceptibility, concerns about vaccine effectiveness, and access to healthcare facilities.
Herpes zoster vaccine utilization among older adults in Saudi Arabia is relatively low despite moderate awareness. Enhancing public education through targeted campaigns and strengthening healthcare provider recommendations are crucial to improving vaccine uptake. Addressing specific barriers and misconceptions is essential to reduce the burden of herpes zoster in this population. The need for future research to explore strategies to overcome these challenges and promote higher vaccination rates is urgent and important.
带状疱疹,即俗称的“生蛇”,是由水痘-带状疱疹病毒(VZV)再激活引起的,对老年人来说是一个重大的健康问题。有效的带状疱疹疫苗的出现为降低这种疾病的发病率和严重程度提供了关键的预防措施。然而,现有疫苗的接种率仍不理想,尤其是在50岁及以上的成年人中。了解影响疫苗使用的因素不仅对于制定提高疫苗接种率的策略至关重要,而且有可能显著减轻疾病负担。
这项横断面研究旨在确定影响沙特阿拉伯初级医疗保健中心50岁及以上成年人使用带状疱疹疫苗的因素。通过向利雅得的瓦扎拉特初级医疗保健中心的就诊者发放经过验证的问卷来收集数据。采用描述性和推断性统计方法对数据进行分析。
共有403名参与者纳入研究,73.7%的参与者听说过这种疾病,但只有34.2%的人接种过疫苗。疫苗接种率与性别、教育水平和医疗保健提供者的建议显著相关。疫苗接种的常见障碍包括担心副作用、缺乏易感性认知、对疫苗有效性的担忧以及获得医疗保健设施的机会。
尽管沙特阿拉伯老年人对带状疱疹疫苗有一定的认知,但疫苗使用率相对较低。通过有针对性的宣传活动加强公众教育以及强化医疗保健提供者的建议对于提高疫苗接种率至关重要。解决特定的障碍和误解对于减轻该人群的带状疱疹负担至关重要。迫切需要开展未来研究,探索克服这些挑战并提高疫苗接种率的策略。